Benzodiazepine Prescribing in Vermont
Medicare Part D, 2013–2024.
Benzodiazepine prescribing in Vermont fell 19.5% between 2013 and 2024 — a steeper fall than the country as a whole. In 2024 the state recorded 73,449 Medicare Part D benzodiazepine claims across 15,567 patients, an average of 4.72 fills per patient per year, which ranks 23 of 51 states. Lorazepam accounts for 39.5% of it.
Vermont over twelve years
Which benzodiazepines Vermont prescribes
| Drug | Claims 2024 | Share |
|---|---|---|
| Lorazepam | 29,021 | 39.5% |
| Clonazepam | 24,260 | 33% |
| Alprazolam | 8,986 | 12.2% |
| Diazepam | 8,598 | 11.7% |
| Temazepam | 1,931 | 2.6% |
Psychiatric prescribers in Vermont
69 psychiatric prescribers in Vermont appear in the 2024 Medicare Part D data with benzodiazepine claims. 17 of them recorded at least a 50% fall in benzodiazepine claims since 2019. Sorted by change, largest reduction first.
This is a record, not a recommendation. A fall in Medicare benzodiazepine claims has many possible explanations — a changing patient panel, retirement, a shift to another payer, or simply dropping below the threshold CMS publishes. It does not establish that a prescriber supports tapering, and a low number does not mean they will take you as a patient. Use it as one input, then ask the five vetting questions.
| Prescriber | City | 2019 | 2024 | Change |
|---|---|---|---|---|
| Desiree BiesheuvelPsychiatry | Springfield | 595 | 12 | -98% |
| Alya ReevePsychiatry | Bennington | 380 | 14 | -96.3% |
| Patricia DalyPsychiatry | Hartford | 229 | 11 | -95.2% |
| Dorothea De GutisPsychiatry | Brattleboro | 357 | 30 | -91.6% |
| Suzan WhiteAddiction Medicine | Saint Albans | 120 | 13 | -89.2% |
| Ethan KarsenPsychiatry | Berlin | 129 | 17 | -86.8% |
| Gwyn CattellPsychiatry | Whiting | 70 | 12 | -82.9% |
| David MooneyPsychiatry | Berlin | 102 | 25 | -75.5% |
| Joseph LasekPsychiatry | Burlington | 202 | 50 | -75.2% |
| Kevin BuchananPsychiatry | Randolph | 746 | 201 | -73.1% |
| Mark McgeePsychiatry | Brattleboro | 174 | 50 | -71.3% |
| Margaret SpottswoodPsychiatry | Burlington | 85 | 27 | -68.2% |
| David AllanPsychiatry & Neurology | Williston | 65 | 21 | -67.7% |
| Harris StrokoffPsychiatry | Berlin | 177 | 59 | -66.7% |
| Clifton LordAddiction Medicine | Windsor | 66 | 24 | -63.6% |
| Holliday RayfieldPsychiatry | Essex Junction | 41 | 15 | -63.4% |
| Robert PierattiniPsychiatry | Burlington | 62 | 30 | -51.6% |
| Richard KastPsychiatry | Burlington | 95 | 50 | -47.4% |
| Jennifer FauntleroyPsychiatry | Rutland | 305 | 175 | -42.6% |
| Paul BoutinPsychiatry | Brattleboro | 79 | 46 | -41.8% |
| Kathleen PittawayPsychiatry & Neurology | Moretown | 201 | 127 | -36.8% |
| Harvey KleinPsychiatry | Burlington | 102 | 69 | -32.4% |
| Linda ZamvilPsychiatry & Neurology | Morrisville | 190 | 132 | -30.5% |
| Gian BentivoglioPsychiatry | Newport | 215 | 150 | -30.2% |
| Sandra SteingardPsychiatry | Burlington | 214 | 154 | -28% |
| Adebowale MofikoyaPsychiatry | Burlington | 161 | 117 | -27.3% |
| Gary KellerPsychiatry | Burlington | 187 | 137 | -26.7% |
| James StonePsychiatry | Montpelier | 442 | 333 | -24.7% |
| Robert DuncanPsychiatry | Montpelier | 722 | 555 | -23.1% |
| Amalia LeePsychiatry & Neurology | Townshend | 38 | 31 | -18.4% |
| James JacobsonPsychiatry | Burlington | 103 | 89 | -13.6% |
| Matthew RichardsonPsychiatry | Burlington | 38 | 33 | -13.2% |
| Lisa Catapano-FriedmanPsychiatry | Bennington | 76 | 67 | -11.8% |
| Robin LessoffPsychiatry | Williston | 96 | 86 | -10.4% |
| Judith TietzPsychiatry | Townshend | 975 | 953 | -2.3% |
| Andrew StollPsychiatry | Montpelier | 307 | 338 | +10.1% |
| Betty MorwoodPsychiatry | South Burlington | 85 | 99 | +16.5% |
| Adam PruettPsychiatry | Rutland | 86 | 102 | +18.6% |
| Jennifer HallGeriatric Psychiatry | Burlington | 102 | 157 | +53.9% |
| Erin HallPsychiatry | Williston | 35 | 66 | +88.6% |
| Terry RabinowitzPsychiatry | Burlington | 32 | 62 | +93.8% |
| Catherine HickeyPsychiatry | Bennington | 59 | 119 | +101.7% |
| Lizabeth PontzerPsychiatry & Neurology | South Burlington | 16 | 43 | +168.8% |
| Thomas SimpaticoPsychiatry & Neurology | Waterbury | 99 | 468 | +372.7% |
| Jenny ShenPsychiatry & Neurology | Burlington | 32 | 160 | +400% |
| Kulsoom KhanPsychiatry | Hartford | — | 348 | — |
| David AppelPsychiatry | Burlington | — | 318 | — |
| Justin KnappPsychiatry | Berlin | — | 158 | — |
| Simha RavvenPsychiatry | Burlington | — | 122 | — |
| Alan FrascoiaPsychiatry | Windsor | — | 98 | — |
| Brian RosenPsychiatry | Berlin | — | 86 | — |
| Amanda NgPsychiatry | South Burlington | — | 74 | — |
| Philip LaplantePsychiatry | Brattleboro | — | 68 | — |
| Julie DebackerPsychiatry & Neurology | Burlington | — | 46 | — |
| Shayer ChowdhuryPsychiatry | Hartford | — | 37 | — |
| Theodore MillerPsychiatry | Bellows Falls | — | 27 | — |
| Jada KhoslaPsychiatry | Montpelier | — | 27 | — |
| Kyle MonahanPsychiatry | Williston | — | 25 | — |
| Jeremiah DickersonPsychiatry | Burlington | — | 23 | — |
| Mason StillmanPsychiatry | Berlin | — | 20 | — |
| Magdalena NaylorPsychiatry | Burlington | — | 19 | — |
| Megan BrennanPsychiatry | Burlington | — | 17 | — |
| Genevieve WilliamsonPsychiatry | North Ferrisburgh | — | 15 | — |
| Judith LewisPsychiatry | Burlington | — | 14 | — |
| Nolan NeuPsychiatry | Berlin | — | 14 | — |
| Lesley BrodiePsychiatry & Neurology | Manchester Center | — | 12 | — |
| William HornPsychiatry & Neurology | Burlington | — | 12 | — |
| Anne CleggPsychiatry | Jericho | — | 11 | — |
| Casey PatunoffPsychiatry | Saint Albans | 11 | 133 | +1109.1% |
Figures are reproduced from the CMS public use files without alteration. Clinicians who believe a row misstates their record can write to support@taperoffbenzos.com and we will check it against the source file and correct or remove it.
Finding a prescriber in Vermont
This data describes prescribing patterns; it does not tell you who will support a slow taper. For that, our guide to finding a benzo-wise prescriber compares every free provider directory that exists and lists the five questions that predict how a taper will go. If you already have a prescriber, the taper calculator generates a schedule to review with them.
Frequently asked questions
Is benzodiazepine prescribing rising or falling in Vermont?
It fell 19.5% between 2013 and 2024 in Medicare Part D — a steeper fall than the country as a whole, where prescribing fell 12.9%. In 2024, Vermont recorded 73,449 benzodiazepine claims across 15,567 patients.
How does Vermont compare to other states?
Vermont ranks 23 of 51 for prescribing intensity, at 4.72 benzodiazepine fills per patient per year, and 16 of 51 for the size of its decline since 2013 (1 being the steepest fall).
Which benzodiazepine is prescribed most in Vermont?
Lorazepam, at 29,021 claims — 39.5% of the state's benzodiazepine prescribing in 2024. Next are Clonazepam (33%) and Alprazolam (12.2%).
Source
CMS Medicare Part D Prescribers public use files, data years 2013–2024 (US Government work, public domain). Medicare Part D only — it excludes commercial insurance and cash-pay, skews toward patients 65 and over, and suppresses cells of 10 or fewer claims. Full methodology and limitations are on the national page.